why choose us

First received: January 20, 2023

Clinical Trial: A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pulmonary Hypertension (World Health Organization Group 2)

Study Type: INTERVENTIONAL


Official Title: A Phase IIb Randomised, Double-blind, Placebo-controlled, Multi-centre, Dose-ranging Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Due to Left Heart Disease (WHO Group

Brief Summary: This study is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart failure (HF) and pulmonary hypertension (PH) Group 2

Read more